Haemonetics Goodwill and Intangible Assets 2010-2024 | HAE

Haemonetics goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Haemonetics Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $971
2023 $742
2022 $778
2021 $832
2020 $344
2019 $339
2018 $368
2017 $388
2016 $472
2015 $579
2014 $608
2013 $595
2012 $212
2011 $217
2010 $210
2009 $122
Haemonetics Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-06-30 $1,108
2024-03-31 $971
2023-12-31 $984
2023-09-30 $716
2023-06-30 $734
2023-03-31 $742
2022-12-31 $750
2022-09-30 $758
2022-06-30 $769
2022-03-31 $778
2021-12-31 $792
2021-09-30 $806
2021-06-30 $820
2021-03-31 $832
2020-12-31 $335
2020-09-30 $342
2020-06-30 $355
2020-03-31 $344
2019-12-31 $318
2019-09-30 $325
2019-06-30 $331
2019-03-31 $339
2018-12-31 $345
2018-09-30 $352
2018-06-30 $360
2018-03-31 $368
2017-12-31 $375
2017-09-30 $381
2017-06-30 $384
2017-03-31 $388
2016-12-31 $453
2016-09-30 $461
2016-06-30 $467
2016-03-31 $472
2015-12-31 $482
2015-09-30 $571
2015-06-30 $576
2015-03-31 $579
2014-12-31 $586
2014-09-30 $594
2014-06-30 $602
2014-03-31 $608
2013-12-31 $612
2013-09-30 $619
2013-06-30 $621
2013-03-31 $595
2012-12-31 $595
2012-09-30 $620
2012-06-30 $210
2012-03-31 $212
2011-12-31 $212
2011-09-30 $214
2011-06-30 $217
2011-03-31 $217
2010-12-31 $211
2010-09-30 $207
2010-06-30 $202
2010-03-31 $210
2009-12-31 $146
2009-09-30 $147
2009-06-30 $137
2009-03-31 $122
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.084B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.617B 25.27
Stryker (SYK) United States $137.290B 32.08
Boston Scientific (BSX) United States $122.743B 37.38
Medtronic (MDT) Ireland $114.552B 17.05
EssilorLuxottica (ESLOY) France $108.842B 0.00
Haleon (HLN) United Kingdom $48.651B 35.57
Lonza Group Ag (LZAGY) Switzerland $46.030B 0.00
ResMed (RMD) United States $35.117B 30.92
Koninklijke Philips (PHG) Netherlands $30.774B 23.39
Terumo (TRUMY) Japan $28.517B 40.27
Zimmer Biomet Holdings (ZBH) United States $22.039B 13.87
Baxter (BAX) United States $19.851B 13.46
Insulet (PODD) United States $16.269B 68.45
Smith & Nephew SNATS (SNN) United Kingdom $13.605B 0.00
Bio-Rad Laboratories (BIO) United States $9.247B 30.63
Demant (WILYY) Denmark $8.667B 0.00
BellRing Brands (BRBR) United States $7.898B 33.39
Lantheus Holdings (LNTH) United States $7.454B 17.89
ICU Medical (ICUI) United States $4.261B 40.67
TG Therapeutics (TGTX) United States $3.689B 39.07
Neogen (NEOG) United States $3.599B 37.75
Prestige Consumer Healthcare (PBH) United States $3.534B 17.61
GN Store Nord (GNNDY) Denmark $3.509B 21.14
Perrigo (PRGO) Ireland $3.499B 11.06
Envista Holdings (NVST) United States $3.398B 18.13
QuidelOrtho (QDEL) United States $3.063B 19.30
Agios Pharmaceuticals (AGIO) United States $2.595B 0.00
Green Thumb Industries (GTBIF) United States $2.226B 37.36
Maravai LifeSciences Holdings (MRVI) United States $2.124B 0.00
LeMaitre Vascular (LMAT) United States $2.061B 54.92
Warby Parker (WRBY) United States $1.614B 0.00
AdaptHealth (AHCO) United States $1.497B 10.81
InMode (INMD) Israel $1.464B 9.32
AtriCure (ATRC) United States $1.372B 0.00
Owens & Minor (OMI) United States $1.247B 9.63
Verano Holdings (VRNOF) United States $1.184B 0.00
BioLife Solutions (BLFS) United States $1.123B 0.00
Evolus (EOLS) United States $1.006B 0.00
PetIQ (PETQ) United States $0.919B 23.30
Phibro Animal Health (PAHC) United States $0.894B 18.55
National Vision Holdings (EYE) United States $0.867B 27.55
Cresco Labs (CRLBF) United States $0.805B 0.00
Surmodics (SRDX) United States $0.549B 116.64
Quanterix (QTRX) United States $0.489B 0.00
VAREX IMAGING (VREX) United States $0.488B 14.72
Jin Medical (ZJYL) China $0.439B 0.00
ZimVie (ZIMV) United States $0.435B 40.41
Valneva SE (VALN) France $0.432B 0.00
Canopy Growth (CGC) Canada $0.402B 0.00
TerrAscend (TSNDF) Canada $0.389B 0.00
Cerus (CERS) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.324B 0.00
OraSure Technologies (OSUR) United States $0.320B 8.25
Aurora Cannabis (ACB) Canada $0.319B 0.00
Biote (BTMD) United States $0.307B 14.18
Viemed Healthcare (VMD) United States $0.283B 30.38
Sanara MedTech (SMTI) United States $0.264B 0.00
Zynex (ZYXI) United States $0.257B 45.00
Utah Medical Products (UTMD) United States $0.232B 15.41
Omeros (OMER) United States $0.227B 0.00
MacroGenics (MGNX) United States $0.200B 0.00
Ayr Wellness (AYRWF) United States $0.194B 0.00
Organigram Holdings (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.163B 67.33
FitLife Brands (FTLF) United States $0.153B 20.64
Brainsway (BWAY) Israel $0.135B 161.40
TriSalus Life Sciences (TLSI) United States $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.121B 0.00
Rockwell Medical (RMTI) United States $0.114B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.111B 11.44
Jushi Holdings (JUSHF) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.101B 24.80
InterCure (INCR) Israel $0.087B 14.62
Zevia PBC (ZVIA) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.082B 0.00
Modular Medical (MODD) United States $0.074B 0.00
Cellectar Biosciences (CLRB) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.071B 0.00
MariMed (MRMD) United States $0.065B 0.00
Exagen (XGN) United States $0.055B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.051B 3.35
Apyx Medical (APYX) United States $0.042B 0.00
Allurion Technologies (ALUR) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GUARDION HEALTH (GHSI) United States $0.007B 0.00
Agape ATP (ATPC) $0.007B 0.00
Leafly Holdings (LFLY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
United-Guardian (UG) United States $0.000B 21.30
SNDL (SNDL) Canada $0.000B 0.00